News: Induction with misoprostol increases postpartum blood loss

Article

Induction at term with misoprostol is associated with a significantly faster labor, but also with a greater postpartum blood loss.

Induction at term with misoprostol is associated with a significantly faster labor (P<.001), but also with significantly greater postpartum blood loss (P=.02) and with a greater difference between pre-and postdelivery hematocrit (P<.001), when compared with induction using oxytocin.

The findings come from a randomized study involving 150 women who completed 40 weeks of pregnancy with a singleton fetus and who were delivering at a university maternity hospital in Egypt.

The researchers found that after oxytocin induction, blood loss ranged from 190 to 800 mL (mean ± SD = 473 ± 155), while the range for misoprostol was 290 to 1,200 mL (573 ± 208).

Elsedeek MS, Awad EE, Elsebaey SM. Evaluation of postpartum blood loss after misoprostol-induced labour. BJOG. 2009;116:431-435.

Related Videos
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
raanan meyer, md
New data shows elinzanetant's efficacy in treating menopausal symptoms | Image Credit: uvahealth.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.